Medicare Enrolled

Dr. Chris Crawford, M. D.

Dermatology · Plano, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
7000 PRESTON RD STE 500, Plano, TX 75024
2149873376
In practice since 2005 (20 years)
NPI: 1447248281 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Crawford from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Crawford? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Crawford

Dr. Chris Crawford is a dermatology specialist in Plano, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Crawford performed 4,839 Medicare services across 2,732 unique beneficiaries.

Between the years covered by Open Payments, Dr. Crawford received a total of $14,531 from 48 pharmaceutical and/or device companies across 1014 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Crawford is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 24% volume in TX $14,531 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,839
Medicare services
Top 24% in TX for dermatology
2,732
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~242 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14 2,109 $5 $14
Office visit, established patient (20-29 min) 958 $58 $186
Destruction of precancerous skin growth, 1 614 $34 $136
Skin biopsy, tangential 359 $66 $217
Destruction of skin growths (warts/lesions), 1-14 141 $80 $236
Steroid injection (triamcinolone) 126 $1 $18
New patient office visit (30-44 min) 106 $65 $228
Office visit, established patient (10-19 min) 94 $33 $115
Biopsy of related skin growth, each additional growth 72 $38 $110
Office visit, established patient (30-39 min) 62 $93 $253
Shaving of skin growth of body, arms, or legs, 0.5 cm or less 43 $64 $215
Biopsy of ear 32 $56 $205
Drug injection, under skin or into muscle 28 $7 $29
Simple or single drainage of skin abscess 24 $73 $254
Destruction of skin growth, 15 or more growths 22 $99 $276
Application of light to destroy precancer skin growth 13 $95 $304
Destruction of precancer skin growth, 15 or more growths 12 $112 $343
New patient office or other outpatient visit, 15-29 minutes 12 $46 $149
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) 12 $304 $781
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,531
Total received (2018-2024)
Avg $2,076/year across 7 years
Top 18% in TX for dermatology
48
Companies
1,014
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,531 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,379
2023
$2,820
2022
$2,476
2021
$1,160
2020
$1,216
2019
$1,567
2018
$1,914

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$1,219
GENZYME CORPORATION
$965
ABBVIE INC.
$915
Janssen Biotech, Inc.
$815
AbbVie Inc.
$753
Sun Pharmaceutical Industries Inc.
$633
Galderma Laboratories, L.P.
$572
Dermavant Sciences, Inc.
$571
Lilly USA, LLC
$568
VYNE Pharmaceuticals Inc.
$567
Novartis Pharmaceuticals Corporation
$552
Almirall LLC
$460
Encore Dermatology Inc.
$458
LEO Pharma Inc.
$457
Incyte Corporation
$456
PFIZER INC.
$447
Arcutis Biotherapeutics, Inc.
$443
AbbVie, Inc.
$429
Amgen Inc.
$396
Ortho Dermatologics, a division of Bausch Health US, LLC
$394
SUN PHARMACEUTICAL INDUSTRIES INC.
$276
MAYNE PHARMA INC.
$256
Allergan Inc.
$230
UCB, Inc.
$201
Allergan, Inc.
$163
Lumenis BE inc
$144
EPI Health, LLC
$137
PruGen, Inc. Pharmaceuticals
$135
E.R. Squibb & Sons, L.L.C.
$116
Nabriva Therapeutics, plc
$109
Journey Medical Corporation
$80
Mayne Pharma Inc.
$65
DUSA Pharmaceuticals, Inc.
$64
MAYNE PHARMA COMMERCIAL LLC
$55
Boehringer Ingelheim Pharmaceuticals, Inc.
$54
DERMIRA, INC.
$50
Sandoz Inc.
$46
Celgene Corporation
$38
Aclaris Therapeutics, Inc.
$35
Paratek Pharmaceuticals, Inc.
$32
Promius Pharma LLC
$31
Verrica Pharmaceuticals Inc.
$29
Medimetriks Pharmaceuticals, Inc.
$27
Mission Pharmacal Company
$21
Biofrontera Inc.
$19
Kyowa Kirin, Inc.
$16
Krystal Biotech Inc
$16
Teva Pharmaceuticals USA, Inc.
$14
Top 3 companies account for 21.3% of total payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · AUSTEDO · Absorica LD · Acticlate · Avar · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BOTOX · BOTOX COSMETIC · BRYHALI · Bimzelx · CIBINQO · CLODERM · COSENTYX · CYLTEZO · Cabtreo · Ceracade · Cimzia · Cordran · Cordran Tape · DALVANCE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · DYSPORT · EBGLYSS · ELIDEL · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Exelderm · FINACEA · HUMIRA · Humira · ILUMYA · Impoyz · JUBLIA · KERYDIN · Klisyri · LEVULAN KERASTICK · LIBTAYO · LITFULO · NUZYRA · OPZELURA · ORACEA · OptiLight · Otezla · Poteligeo · QBREXZA · REMICADE · RHOFADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · Sernivo · Sernivo Spray · Seysara · Sitavig · Sivextro · Skyrizi · Sotyktu · TALTZ · TREMFYA · TWYNEO · Tazorac · ULTRAVATE · VTAMA · VYJUVEK · Veltin · Winlevi · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $300 per 100 Medicare services performed
Looking for a dermatology specialist in Plano?
Compare dermatologists in the Plano area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
207
Per 100K population
18.5
County median income
$117,588
Nearest hospital
CHILDRENS MEDICAL CENTER PLANO
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Crawford is a clinical cardiology specialist, with above-average Medicare volume (top 24% in TX), with low-engagement industry engagement in the top 18% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Crawford experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Crawford performed 2,109 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Crawford receive payments from pharmaceutical companies?
Yes. Dr. Crawford received a total of $14,531 from 48 companies across 1,014 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Crawford's costs compare to other dermatologists in Plano?
Dr. Crawford's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Crawford) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →